Sugi Predict

Sugi Predict / Compounds / SCHEMBL347596

SCHEMBL347596

SCHEMBL347596

C=CCC(=O)OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ TDP1 Q9NUW8 2/20 0.52
▸ SLC6A2 P23975 1/20 0.52
▸ SLC6A3 Q01959 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ HCAR2 Q8TDS4 1/20 0.51
▸ LMNA P02545 3/20 0.49
▸ GAA P10253 1/20 0.48
▸ TGM2 P21980 1/20 0.47
▸ CDC25B P30305 1/20 0.46
▸ HTT P42858 1/20 0.45
▸ CA12 O43570 1/20 0.45
▸ AKR1B10 O60218 1/20 0.45
▸ AKR1B1 P15121 1/20 0.45
▸ CA4 P22748 1/20 0.45
▸ CA6 P23280 1/20 0.45
▸ CA5A P35218 1/20 0.45
▸ CA7 P43166 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27585088 0.98 ALDH1A1 (0.59) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2
SCHEMBL3753179 0.87 ALDH1A1 (0.47) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2
SCHEMBL9568209 0.85 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2
SCHEMBL6650547 0.85 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2
SCHEMBL6711344 0.85 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2
SCHEMBL2562532 0.83 ALDH1A1 (0.63) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2
SCHEMBL2465566 0.82 ALDH1A1 (0.58) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2
SCHEMBL7636504 0.82 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2
SCHEMBL16672547 0.82 TDP1 (0.58) ALDH1A1MAPK1L3MBTL1TDP1HCAR2
SCHEMBL27914737 0.82 ALDH1A1 (0.41) ALDH1A1MAPK1L3MBTL1TDP1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117088786-A Eptification intermediate and preparation method thereof 上海医药工业研究院有限公司 2023-11-21 — — CN claimed
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2023-03-30 — — US claimed
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2022-06-09 — — US claimed
EP-3938359-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF 6th Wave Innovations Corp. (US) 2022-01-19 — — EP claimed
WO-2020186077-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF 6th Wave Innovations Corp. (US) 2020-09-17 — — WO claimed
US-7678870-B2 Processable molecularly imprinted polymers THE JOHNS HOPKINS UNIVERSITY (US) 2010-03-16 — — US claimed
US-20070197746-A1 Processable molecularly imprinted polymers THE JOHNS HOPKINS UNIVERSITY 2007-08-23 — — US claimed
EP-1733211-A4 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS UNIV JOHNS HOPKINS (US) 2007-05-30 — — EP claimed
EP-1733211-A1 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS THE JOHNS-HOPKINS UNIVERSITY (US) 2006-12-20 — — EP claimed
WO-2005103655-A1 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2005-11-03 — — WO claimed
EP-1509302-A1 SOLID MYCOCTOXIN CARRIERS Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung (AT) 2005-03-02 — — EP claimed
WO-2003101580-A1 SOLID MYCOCTOXIN CARRIERS Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung (AT) 2003-12-11 — — WO claimed
EP-0282724-A1 Negative resist compositions International Business Machines Corporation (US) 1988-09-21 — — EP claimed
US-4360609-A VINYLAROMATIC POLYMER, ACTIVE ALLYL OR BENZYL CARBON, ARYLSULFONATE CATALYST THE DOW CHEMICAL COMPANY (US) 1982-11-23 — — US claimed
EP-4375353-B1 VISCOSITY MODIFIER FOR LUBRICATING OIL, AND LUBRICATING OIL COMPOSITION FOR HYDRAULIC OIL MITSUI CHEMICALS INC (JP) 2026-05-27 — — EP disclosed
US-12630521-B2 Arylamides and methods of use thereof GENZYME CORPORATION (US) 2026-05-19 — — US disclosed
US-20260070917-A1 CYCLIN DEPENDENT KINASE DEGRADERS AND METHODS OF USE THEREOF DIFFERENTIATED THERAPEUTICS INC (US) 2026-03-12 — — US disclosed
EP-0318425-A1 Derivatives of 2,2-difluorcyclopropyl ethane, process for their preparation and their use in pest control SCHERING AKTIENGESELLSCHAFT (DE) 1989-05-31 — — EP disclosed
US-4800152-A Negative resist compositions INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1989-01-24 — — US disclosed
EP-0282724-A1 Negative resist compositions International Business Machines Corporation (US) 1988-09-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT ALDH1A1 3487/4885MAPK1 3836/4885L3MBTL1 3502/4885
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT ALDH1A1 3487/4885MAPK1 3836/4885L3MBTL1 3502/4885
US-12630521-B2 Arylamides and methods of use thereof CFTR, CLIC1, CLCN2 ALDH1A1 905/4885MAPK1 3612/4885L3MBTL1 1604/4885
US-20260070917-A1 CYCLIN DEPENDENT KINASE DEGRADERS AND METHODS OF USE THEREOF CDK2, CCNK, CCNC ALDH1A1 2041/4885MAPK1 1386/4885L3MBTL1 3249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.